Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone

PURPOSE: To evaluate whether response assessment of newly diagnosed glioblastoma at 3 months using (11)C-methionine-positron emission tomography (MET-PET) is better associated with patient outcome compared with baseline MET-PET or anatomic magnetic resonance imaging alone. METHODS AND MATERIALS: Pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Radiat Oncol
Autors principals: Miller, Sean, Li, Pin, Schipper, Matthew, Junck, Larry, Piert, Morand, Lawrence, Theodore S., Tsien, Christina, Cao, Yue, Kim, Michelle M.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Central Nervous System Tumor
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004943/
https://ncbi.nlm.nih.gov/pubmed/32051890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2019.08.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars